{"DataElement":{"publicId":"6042921","version":"1","preferredName":"Injection Site Adverse Event Injection Site Adverse Event Type","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._Something distinguishable as an identifiable class based on common qualities.","longName":"INJ_SIT_AE_TYPE","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"6042914","version":"1","preferredName":"Injection Site Adverse Event","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","longName":"6042912v1.0:2716691v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"6042912","version":"1","preferredName":"Injection Site","preferredDefinition":"The anatomic site at which a medication or a vaccine is injected.","longName":"C77680","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Site","conceptCode":"C77680","definition":"The anatomic site at which a medication or a vaccine is injected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60517D73-D7FD-346B-E053-F662850AD2F9","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"ONEDATA","dateModified":"2017-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2716691","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41CDC6A6-1F86-6234-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-21","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-12-21","modifiedBy":"ONEDATA","dateModified":"2007-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"60517D73-D80B-346B-E053-F662850AD2F9","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"TSESU","dateModified":"2017-12-25","changeDescription":"MAY2016.08.01_12.14.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6042919","version":"1","preferredName":"Injection Site Adverse Event Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6042919v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, specify","valueDescription":"Specify Other","ValueMeaning":{"publicId":"4888051","version":"1","preferredName":"Specify Other","longName":"4888051","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"195A90B1-87F5-D292-E050-BB89AD432B03","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"605291C2-3890-41C5-E053-F662850AB413","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"ONEDATA","dateModified":"2017-12-14","deletedIndicator":"No"},{"value":"Induration/Swelling","valueDescription":"Induration And/Or Swelling","ValueMeaning":{"publicId":"6042920","version":"1","preferredName":"Induration And/Or Swelling","longName":"6042920","preferredDefinition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.: Used to indicate that either or both of two items or options may be valid.: Enlargement; expansion in size; sign of inflammation","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Induration","conceptCode":"C25534","definition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Swelling","conceptCode":"C3399","definition":"Enlargement; expansion in size; sign of inflammation","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"605291C2-389F-41C5-E053-F662850AB413","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"605291C2-38B8-41C5-E053-F662850AB413","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"ONEDATA","dateModified":"2017-12-14","deletedIndicator":"No"},{"value":"Erythema/Redness","valueDescription":"Erythema","ValueMeaning":{"publicId":"5777503","version":"1","preferredName":"Erythema","longName":"5777503","preferredDefinition":"Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythema","conceptCode":"C26901","definition":"Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D8745C5-4388-3769-E053-F662850A662D","latestVersionIndicator":"Yes","beginDate":"2017-04-19","endDate":null,"createdBy":"PATELV","dateCreated":"2017-04-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"605291C2-38CC-41C5-E053-F662850AB413","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"ONEDATA","dateModified":"2017-12-14","deletedIndicator":"No"},{"value":"Tenderness ","valueDescription":"Tender","ValueMeaning":{"publicId":"2582454","version":"1","preferredName":"Tender","longName":"2582454","preferredDefinition":"Discomfort elicited through touch or pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tenderness","conceptCode":"C75540","definition":"Discomfort elicited through touch or pressure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0F23-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-12","modifiedBy":"REEVESD","dateModified":"2013-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"605291C2-38E1-41C5-E053-F662850AB413","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"ONEDATA","dateModified":"2017-12-14","deletedIndicator":"No"},{"value":"Pain ","valueDescription":"Pain","ValueMeaning":{"publicId":"4395777","version":"1","preferredName":"Pain","longName":"4395777","preferredDefinition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DA1E-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"605291C2-38F6-41C5-E053-F662850AB413","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"ONEDATA","dateModified":"2017-12-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"605291C2-3879-41C5-E053-F662850AB413","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"TSESU","dateModified":"2017-12-25","changeDescription":"MAY2016.08.01_ghd_12.14.17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"6025104","version":"1","longName":"MAY2016-08-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reaction","type":"Preferred Question Text","description":"Reaction","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6053020F-F6A4-56BA-E053-F662850AFC9B","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-12-14","modifiedBy":"TSESU","dateModified":"2017-12-25","changeDescription":"MAY2016.08.01_ghd_12.14.17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}